FdaApplication
NDA 021007
Identifiers
- fda_app_no: NDA021007
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1999-04-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AGENERASE | AMPRENAVIR | 150MG | CAPSULE;ORAL |
| AGENERASE | AMPRENAVIR | 50MG | CAPSULE;ORAL |
2 products